Board of Directors
Jarne has over 30 years of experience in a variety of managerial roles, including ICT, Life Science and Medtech. He has extensive venture capital experience having run and managed three Danish venture funds with 24 portfolio companies, working with entrepreneurs and developing start-up and early stage growth companies towards exit.
Jarne was Chairman of Scandinavian Micro Biodevices, an animal health company, helping them grow and finally divesting them to Zoetis. He has a strong network in the European venture capital community and will look to develop existing portfolio companies and provide new syndication partners for Stonehaven Incubate.
Robert E. Farrell Jr., CPA is the Senior Vice President of Finance/Operations and Chief Accounting Officer at Morphic Therapeutic Inc. and was part of the initial company formation in June 2015. Prior to joining Morphic Therapeutic, he served as Vice President of Finance and Administration and Treasurer of Genocea Biosciences from 2009 to 2015. Before that, he held senior level financial positions at Oscient Pharmaceuticals, Magen Biosciences and NeoGenesis Pharmaceuticals, Inc., where he directed companies through multiple private financings, acquisitions and several public offerings. Mr. Farrell is a licensed certified public accountant and holds a B.S. degree in accounting from Bentley University.
After graduating from the veterinary program at the University of Bristol, U.K., with honors, in 1991 Dr. Lascelles completed a PhD in aspects of pre-emptive/perioperative analgesia at the University of Bristol. After an internship there, he completed his surgical residency at the University of Cambridge, U.K. He moved to Colorado for the Fellowship in Oncological Surgery at Colorado State University, then a period of post-doctoral research in feline pain and analgesia at the University of Florida, and is currently Professor in Small Animal Surgery and Pain Management at North Carolina State University. He is board-certified in small animal surgery by the Royal College of Veterinary Surgeons, the European College of Veterinary Surgeons, and the American College of Veterinary Surgeons.
He is director of the Comparative Pain Research and Education Centre (CPREC). His research program (Translational Research in Pain [TRiP]) is dedicated to answering critical questions about pain control and pain mechanisms through high quality, innovative research. His career has been focused on developing algometry methods (methods to measure pain) in spontaneous disease animal models (pets with naturally occurring disease), and probing tissues from well-phenotyped animals with spontaneous disease to understand the neurobiology, with a strong translational focus. The aim of his research is to improve pain control in companion animals, and facilitate analgesic development in human medicine. He has authored over 180 peer reviewed research papers and reviews and 190 research abstracts, as well as over 30 book chapters.
Charlie has over 20 years of experience in strategy, marketing and leadership in the life sciences sector. Prior to joining Stonehaven Incubate, he led the transformational restructure of two major pharmaceutical companies and generated savings of up to US$50 million in capital.
Between 2001 and 2017 Charlie held senior roles at Novartis Animal Health, Novartis Consumer Health and GSK Consumer Health. Later, he founded GRO Strategies and worked as a Senior Advisor at Stonehaven Consulting.
Siddhesh Angle, PhD
His career in musculoskeletal research & development spans 15 years. Dr. Angle played an integral role in the acquisition of a synthetic biomaterials start-up by Zimmer Biomet. He was then R&D Manager for their Global Biologics business and has successfully commercialized several orthopedic medical devices and combination therapies.